Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • Eager Eagle
    link
    English
    91 year ago

    We may and should point to all questionably bad practices of these drug companies, but I think humanity is still far better off with their research advancements than without them. So I’m all for using my data for that purpose like 23andMe is doing. Now insurance companies and lobbyists - these can go to hell.